Compare Agilent Technologies Inc (A) vs Lululemon Athletica Inc (LULU) Price & Performance

Agilent Technologies (A) trades at $148.77, up 0.03% on the day, near its consensus price target of $154.90. The stock shows bullish technical signals with strong moving average support, though RSI indicates overbought conditions. Recent earnings beat expectations in Q1 2026, and the company maintains robust profitability with a 19.55% net income margin. Key developments include FDA and EU regulatory approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its biopharma portfolio.

Outlook remains positive with analyst consensus at Buy (77.5%) and a projected 4.1% upside to the price target. Risks include elevated valuation multiples (P/E 30.02) and dependence on healthcare sector growth. Earnings on August 26, 2026, will be critical for validating continued momentum amid competitive and macroeconomic pressures.

Lululemon (LULU) trades at $121.4, down 5.01% amid broader market weakness in the premium apparel sector. The stock shows strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.69 beating expectations of $1.67. Valuation metrics appear attractive with P/E of 10.17 and P/S of 1.32, while profitability remains robust with 55.7% gross margins and 32.03% ROE. Technical indicators show a bullish moving average trend despite overbought RSI readings.

LULU presents a compelling investment case with undervalued metrics and strong international growth potential, particularly in China. However, risks include U.S. market softness and competitive pressures in the premium activewear space. The consensus price target of $129.29 suggests 6.5% upside potential from current levels, supported by 40.85% analyst buy ratings.